Exact Mass: 386.2304

Exact Mass Matches: 386.2304

Found 66 metabolites which its exact mass value is equals to given mass value 386.2304, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Oleandolide

Oleandolide

C20H34O7 (386.2304)


A 14-membererd macrolide containing ten stereocentres carrying one epoxymethano, three hydroxy and five methyl substituents. It is the aglycone of the antibiotic oleandomycin.

   

10,11-dihydro-20-trihydroxy-leukotriene B4

(5R,6Z,8E,12R,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,14-trienoic acid

C20H34O7 (386.2304)


10,11-dihydro-20-trihydroxy-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region, and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by omega-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the omega-carboxy position and after CoA ester formation (PMID: 7649996, 17623009, 2853166, 6088485). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 10,11-Dihydro-20-trihydroxy-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 7649996, 17623009, 2853166, 6088485)

   

(Z)-7-[(1R,2R,3R,5S)-2-(1,2-Dihydroxy-3-oxooctyl)-3,5-dihydroxycyclopentyl]hept-5-enoic acid

(Z)-7-[(1R,2R,3R,5S)-2-(1,2-Dihydroxy-3-oxooctyl)-3,5-dihydroxycyclopentyl]hept-5-enoic acid

C20H34O7 (386.2304)


   

1-[Fluoro(methoxy)phosphoryl]oxyicosa-5,8,11,14-tetraene

Icosa-5,8,11,14-tetraen-1-yl methyl fluorophosphonic acid

C21H36FO3P (386.2386)


   

DTXSID50958764

DTXSID50958764

C20H34O7 (386.2304)


   
   

Rhodomollein XIV

Rhodomollein XIV

C20H34O7 (386.2304)


   
   

MEGxm0_000239

MEGxm0_000239

C20H34O7 (386.2304)


   

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-((4-hydroxycyclohexyl)methyl)-1h-indazole-3-carboxamide

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-((4-hydroxycyclohexyl)methyl)-1h-indazole-3-carboxamide

C21H30N4O3 (386.2318)


   

1-acetyl-16-methoxy-aspidospermidine-17,21-diol|3-Methoxy-limapodin

1-acetyl-16-methoxy-aspidospermidine-17,21-diol|3-Methoxy-limapodin

C22H30N2O4 (386.2205)


   

12-Hydroxy-11-methoxyspermostrychnine

12-Hydroxy-11-methoxyspermostrychnine

C22H30N2O4 (386.2205)


   

3beta,7beta,8beta,12zeta,17-pentahydroxylabdan-16,15-olide

3beta,7beta,8beta,12zeta,17-pentahydroxylabdan-16,15-olide

C20H34O7 (386.2304)


   

Icariside B5

Icariside B5

C20H34O7 (386.2304)


   

sarconepaside A

sarconepaside A

C20H34O7 (386.2304)


   

Deacylpieristoxin F

Deacylpieristoxin F

C20H34O7 (386.2304)


   

2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid

NCGC00179830-03!2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid

C20H34O7 (386.2304)


   

2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid

2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid

C20H34O7 (386.2304)


   

2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based: Match]

NCGC00179830-03!2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based: Match]

C20H34O7 (386.2304)


   

2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000845048]

NCGC00179830-03!2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000845048]

C20H34O7 (386.2304)


   

2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000845049]

NCGC00179830-03!2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000845049]

C20H34O7 (386.2304)


   

2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid_major

2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid_major

C20H34O7 (386.2304)


   

2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid_minor

2-[5-[2-[2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid_minor

C20H34O7 (386.2304)


   

FA 20:3;O5

(5R,6Z,8E,12R,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,14-trienoic acid

C20H34O7 (386.2304)


   

Berkeleylactone M

4R-hydroxy-5S-succinyl-15R-hexadecanolide

C20H34O7 (386.2304)


   

Berkeleylactone O

5S-succinyl,15R-hydroxy-hexadeca-4R-olide

C20H34O7 (386.2304)


   
   

N-(2-aminoethyl)ethane-1,2-diamine,2-(chloromethyl)oxirane,hexanedioic acid,N-methylmethanamine

N-(2-aminoethyl)ethane-1,2-diamine,2-(chloromethyl)oxirane,hexanedioic acid,N-methylmethanamine

C15H35ClN4O5 (386.2296)


   

1-hexadecyl-3-methylimidazolium bromide

1-hexadecyl-3-methylimidazolium bromide

C20H39BrN2 (386.2296)


   

butyl 2-methylprop-2-enoate,2-hydroxypropyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

butyl 2-methylprop-2-enoate,2-hydroxypropyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

C20H34O7 (386.2304)


   

1-Butyl-8-(3-noradamantyl)-3-(3-hydroxypropyl)xanthine

1-Butyl-8-(3-noradamantyl)-3-(3-hydroxypropyl)xanthine

C21H30N4O3 (386.2318)


PSB36 is a potent and selective antagonist of adenosine A1 receptor, with Kis 0.12 nM, 187 nM, 552 nM, 2300 nM, and 6500 nM for rA1, hA2B, rA2A, hA3 and rA3 receptors respectively. PSB36 can be used for the research of hyperalgesia[1][2].

   

N-(4,6-dimethyl-2-pyrimidinyl)-1,3-bis(phenylmethyl)-2,4-dihydro-1,3,5-triazin-6-amine

N-(4,6-dimethyl-2-pyrimidinyl)-1,3-bis(phenylmethyl)-2,4-dihydro-1,3,5-triazin-6-amine

C23H26N6 (386.2219)


   

(8R)-8-({3,6-dideoxy-4-O-[(2E)-2-methylbut-2-enoyl]-alpha-L-arabino-hexopyranosyl}oxy)nonanoic acid

(8R)-8-({3,6-dideoxy-4-O-[(2E)-2-methylbut-2-enoyl]-alpha-L-arabino-hexopyranosyl}oxy)nonanoic acid

C20H34O7 (386.2304)


   

(1s,3r,4s,5s,7s)-4-{[2-(4-Methoxyphenoxy)-2-Methylpropanoyl]amino}adamantane-1-Carboxamide

(1s,3r,4s,5s,7s)-4-{[2-(4-Methoxyphenoxy)-2-Methylpropanoyl]amino}adamantane-1-Carboxamide

C22H30N2O4 (386.2205)


   

(S)-N-(4-Carbamimidoylbenzyl)-1-(2-(Cyclohexyloxy)ethanoyl)pyrrolidine-2-Carboxamide

(S)-N-(4-Carbamimidoylbenzyl)-1-(2-(Cyclohexyloxy)ethanoyl)pyrrolidine-2-Carboxamide

C21H30N4O3 (386.2318)


   

ambiguine L isonitrile

ambiguine L isonitrile

C26H30N2O (386.2358)


   

1-[Fluoro(methoxy)phosphoryl]oxyicosa-5,8,11,14-tetraene

1-[Fluoro(methoxy)phosphoryl]oxyicosa-5,8,11,14-tetraene

C21H36FO3P (386.2386)


   

(E)-7-[2-(1,2-dihydroxy-3-oxooctyl)-3,5-dihydroxycyclopentyl]hept-5-enoic acid

(E)-7-[2-(1,2-dihydroxy-3-oxooctyl)-3,5-dihydroxycyclopentyl]hept-5-enoic acid

C20H34O7 (386.2304)


   

8-[4-(2,3-Dihydro-1,4-benzodioxin-3-ylmethylamino)butyl]-8-azaspiro[4.5]decane-7,9-dione

8-[4-(2,3-Dihydro-1,4-benzodioxin-3-ylmethylamino)butyl]-8-azaspiro[4.5]decane-7,9-dione

C22H30N2O4 (386.2205)


   

(4R,7R)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4R,7R)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C21H30N4O3 (386.2318)


   

(4S,7S)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4S,7S)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C21H30N4O3 (386.2318)


   

(5S,8S)-8-[(4-methoxyphenyl)methyl]-5-(2-methylpropyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

(5S,8S)-8-[(4-methoxyphenyl)methyl]-5-(2-methylpropyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C21H30N4O3 (386.2318)


   

(4S,7R)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4S,7R)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C21H30N4O3 (386.2318)


   

(4R,7S)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4R,7S)-4-[(4-methoxyphenyl)methyl]-7-(2-methylpropyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C21H30N4O3 (386.2318)


   

(5S,8R)-8-[(4-methoxyphenyl)methyl]-5-(2-methylpropyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

(5S,8R)-8-[(4-methoxyphenyl)methyl]-5-(2-methylpropyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C21H30N4O3 (386.2318)


   

(5S,6Z,8E,12S,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,14-trienoic acid

(5S,6Z,8E,12S,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,14-trienoic acid

C20H34O7 (386.2304)


   

Lobohedleolide pryazoline methyl ester

Lobohedleolide pryazoline methyl ester

C22H30N2O4 (386.2205)


   

(1R,2S,5R)-5-Methyl-2-(1-methyl-1-(2-naphthyl)ethyl)-cyclohexane-1-YL benzoate

(1R,2S,5R)-5-Methyl-2-(1-methyl-1-(2-naphthyl)ethyl)-cyclohexane-1-YL benzoate

C27H30O2 (386.2246)


   

mbas#10

mbas#10

C20H34O7 (386.2304)


A 4-O-[(E)-2-methyl-2-butenoyl]ascaroside derived from (8R)-8-hydroxynonanoic acid. It is a metabolite of the nematode Caenorhabditis elegans.

   

(1s,3r,4r,6r,7s,8s,9r,10r,13r,14r,16s)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol

(1s,3r,4r,6r,7s,8s,9r,10r,13r,14r,16s)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol

C20H34O7 (386.2304)


   

1,2,4-trimethyl (1s)-1-(dec-9-en-1-yl)-2-hydroxybutane-1,2,4-tricarboxylate

1,2,4-trimethyl (1s)-1-(dec-9-en-1-yl)-2-hydroxybutane-1,2,4-tricarboxylate

C20H34O7 (386.2304)


   

(1s,3r,4s,6r,7r,8r,9s,10r,13r,14s,16r)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol

(1s,3r,4s,6r,7r,8r,9s,10r,13r,14s,16r)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol

C20H34O7 (386.2304)


   

3-{1-hydroxy-2-[2,3,6-trihydroxy-2-(hydroxymethyl)-5,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]ethyl}oxolan-2-one

3-{1-hydroxy-2-[2,3,6-trihydroxy-2-(hydroxymethyl)-5,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]ethyl}oxolan-2-one

C20H34O7 (386.2304)


   

5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol

5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol

C20H34O7 (386.2304)


   

(1r,2s,3r,4r,6s,8s,9r,10r,13r,14r,16r)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-2,3,4,6,9,14,16-heptol

(1r,2s,3r,4r,6s,8s,9r,10r,13r,14r,16r)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-2,3,4,6,9,14,16-heptol

C20H34O7 (386.2304)


   

2,6,6,12-tetramethyltetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadecane-2,4,5,7,8,10,12-heptol

2,6,6,12-tetramethyltetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadecane-2,4,5,7,8,10,12-heptol

C20H34O7 (386.2304)


   

(3r)-3-[(1s)-2-[(1r,2s,3s,4ar,6s,8as)-2,3,6-trihydroxy-2-(hydroxymethyl)-5,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]oxolan-2-one

(3r)-3-[(1s)-2-[(1r,2s,3s,4ar,6s,8as)-2,3,6-trihydroxy-2-(hydroxymethyl)-5,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]oxolan-2-one

C20H34O7 (386.2304)


   

(1r,2r,3s,4r,5r,7r,8r,10s,12r,13r,16r)-2,6,6,12-tetramethyltetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadecane-2,4,5,7,8,10,12-heptol

(1r,2r,3s,4r,5r,7r,8r,10s,12r,13r,16r)-2,6,6,12-tetramethyltetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadecane-2,4,5,7,8,10,12-heptol

C20H34O7 (386.2304)


   

1,2,4-trimethyl 1-(dec-9-en-1-yl)-2-hydroxybutane-1,2,4-tricarboxylate

1,2,4-trimethyl 1-(dec-9-en-1-yl)-2-hydroxybutane-1,2,4-tricarboxylate

C20H34O7 (386.2304)


   

(1r,3s,4r,6s,7s,8s,9s,10r,13s,14r,16r)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol

(1r,3s,4r,6s,7s,8s,9s,10r,13s,14r,16r)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol

C20H34O7 (386.2304)


   

(4s)-4-hydroxy-3,5,5-trimethyl-4-[(3r)-3-{[(1r,2r,3s,4r,5r)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxy}butyl]cyclohex-2-en-1-one

(4s)-4-hydroxy-3,5,5-trimethyl-4-[(3r)-3-{[(1r,2r,3s,4r,5r)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxy}butyl]cyclohex-2-en-1-one

C20H34O7 (386.2304)


   

1-[(1s,9s,12s,13s,19r)-12-ethyl-6,13-dihydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5-trien-8-yl]ethanone

1-[(1s,9s,12s,13s,19r)-12-ethyl-6,13-dihydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5-trien-8-yl]ethanone

C22H30N2O4 (386.2205)


   

1-{12-ethyl-6,13-dihydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5-trien-8-yl}ethanone

1-{12-ethyl-6,13-dihydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5-trien-8-yl}ethanone

C22H30N2O4 (386.2205)


   

(1s,3r,4r,6r,7s,8s,9r,10r,13r,14r,16r)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol

(1s,3r,4r,6r,7s,8s,9r,10r,13r,14r,16r)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,14,16-heptol

C20H34O7 (386.2304)


   

rhodojaponin vi

rhodojaponin vi

C20H34O7 (386.2304)


   

5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-2,3,4,6,9,14,16-heptol

5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-2,3,4,6,9,14,16-heptol

C20H34O7 (386.2304)